Search

everythinglearnresearchcommunity

for

Search:↓

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Tofacitinib may effectively treat folliculitis decalvans.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Upadacitinib improved multiple immune-related conditions in one patient.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Topical tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Low dose valproic acid treatment caused hair loss in a young patient.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

A patient with complete hair loss regrew all her hair using tofacitinib.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.